Osteogenesis imperfecta-pathophysiology and therapeutic options.

Etich, Julia; Leßmeier, Lennart; Rehberg, Mirko; Sill, Helge; Zaucke, Frank; Netzer, Christian; Semler, Oliver

Etich, Julia; Leßmeier, Lennart; Rehberg, Mirko; Sill, Helge; Zaucke, Frank; Netzer, Christian; Semler, Oliver.

Afiliación

Etich J; Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, Frankfurt/Main, Germany.
Leßmeier L; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Human Genetics, Cologne, Germany.
Rehberg M; Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, Cologne, Germany.
Sill H; Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, Cologne, Germany.
Zaucke F; Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, Frankfurt/Main, Germany.
Netzer C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Human Genetics, Cologne, Germany.
Semler O; Faculty of Medicine and University Hospital Cologne, Center for rare diseases, University of Cologne, Cologne, Germany.

Mol Cell Pediatr ; 7(1): 9, 2020 Aug 14.

Article en En | MEDLINE | ID: mdl-32797291

Palabras clave

Bisphosphonates; Genetic heterogeneity; Osteogenesis imperfecta; Pathophysiology; Therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Cell Pediatr Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google